Histone H4 acetylation by immunohistochemistry and prognosis in newly diagnosed adult acute lymphoblastic leukemia (ALL) patients

BACKGROUND: Histone deacetylase (HDAC) inhibitors are a novel anti-tumor therapy. To determine whether HDAC inhibitors may be useful in the treatment of adult acute lymphoblastic leukemia (ALL), we examined the acetylation of histone H4 by immunohistochemistry in newly diagnosed ALL patients and eva...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Advani, Anjali S, Gibson, Sarah E, Douglas, Elizabeth, Jin, Tao, Zhao, Xiaoxian, Kalaycio, Matt, Copelan, Ed, Sobecks, Ronald, Sekeres, Mikkael, Sungren, Shawnda, Hsi, Eric D
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2010
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2921396/
https://ncbi.nlm.nih.gov/pubmed/20663136
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-10-387
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars